NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome.
暂无分享,去创建一个
D. Sahali | A. Pawlak | M. Ollero | V. Guigonis | V. Audard | J. Oniszczuk | Kélhia Sendeyo | Pauline Vachin | Carole Hénique | Shao-yu Zhang | A. Boumédiène